CANNAPHARMARX, INC. Research And Development Expense

Quick Answer

CANNAPHARMARX, INC. reported Research And Development Expense of $324.1 thousand for the year ending 2014.

  • This data is from CANNAPHARMARX, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2015.
  • XBRL data for this metric is available from 2014 to 2014 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2014: $37.2 thousand | Q3 2014: $135.1 thousand | Q1 2015: $160.8 thousand | Q2 2015: $161.7 thousand | Q3 2015: $145.8 thousand.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: